-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Lower-Risk Myelodysplastic Syndromes

Ticketed Session
Program: How I Treat: Bringing Science to Clinical Dilemmas
Sunday, December 6, 2015: 11:15 AM-12:15 PM
Bayhill 24 (Hyatt Regency Orlando)
Speaker:
David P. Steensma, MD, Dana-Farber Cancer Institute

Disclosures:
Steensma: Celgene: Consultancy ; Amgen: Consultancy ; Incyte: Consultancy ; Onconova: Consultancy .
See more of: How I Treat: Bringing Science to Clinical Dilemmas
<< Previous Session | Next Session >>